These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 19495523

  • 1. Serum sex hormone levels in pre- and postmenopausal breast cancer patients.
    Ho CC, Rohaizak M, Zulkifli SZ, Siti-Aishah MA, Nor-Aini U, Sharifah-Noor-Akmal SH.
    Singapore Med J; 2009 May; 50(5):513-8. PubMed ID: 19495523
    [Abstract] [Full Text] [Related]

  • 2. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E.
    J Natl Cancer Inst; 2005 May 18; 97(10):755-65. PubMed ID: 15900045
    [Abstract] [Full Text] [Related]

  • 3. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.
    J Natl Cancer Inst; 2006 Oct 04; 98(19):1406-15. PubMed ID: 17018787
    [Abstract] [Full Text] [Related]

  • 4. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):595-602. PubMed ID: 15840882
    [Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA, Borofsky ND, Massardo S, Orentreich N.
    Cancer Epidemiol Biomarkers Prev; 2002 Dec 20; 11(12):1566-73. PubMed ID: 12496045
    [Abstract] [Full Text] [Related]

  • 6. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.
    J Natl Cancer Inst; 2004 Dec 15; 96(24):1856-65. PubMed ID: 15601642
    [Abstract] [Full Text] [Related]

  • 7. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.
    J Natl Cancer Inst; 2006 Jan 18; 98(2):110-5. PubMed ID: 16418513
    [Abstract] [Full Text] [Related]

  • 8. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z, Gardi J, Nyári T, Földesi I, Hajnal-Papp R, Ormándi K, Lázár G, Thurzó L, Schally AV.
    Int J Oncol; 2006 Jul 18; 29(1):193-200. PubMed ID: 16773200
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A prospective study of estradiol and breast cancer in Japanese women.
    Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE.
    Cancer Epidemiol Biomarkers Prev; 2000 Jun 18; 9(6):575-9. PubMed ID: 10868691
    [Abstract] [Full Text] [Related]

  • 11. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
    Tworoger SS, Eliassen AH, Sluss P, Hankinson SE.
    J Clin Oncol; 2007 Apr 20; 25(12):1482-8. PubMed ID: 17372279
    [Abstract] [Full Text] [Related]

  • 12. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
    Tworoger SS, Sluss P, Hankinson SE.
    Cancer Res; 2006 Feb 15; 66(4):2476-82. PubMed ID: 16489055
    [Abstract] [Full Text] [Related]

  • 13. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women.
    Baglietto L, Severi G, English DR, Krishnan K, Hopper JL, McLean C, Morris HA, Tilley WD, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2010 Feb 15; 19(2):492-502. PubMed ID: 20086116
    [Abstract] [Full Text] [Related]

  • 14. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
    Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw KT, Allen NE, Bueno-de-Mesquita HB, van Gils CH, Grobbee D, Boeing H, Lahmann PH, Nagel G, Chang-Claude J, Clavel-Chapelon F, Fournier A, Thiébaut A, González CA, Quirós JR, Tormo MJ, Ardanaz E, Amiano P, Krogh V, Palli D, Panico S, Tumino R, Vineis P, Trichopoulou A, Kalapothaki V, Trichopoulos D, Ferrari P, Norat T, Saracci R, Riboli E.
    Endocr Relat Cancer; 2005 Dec 15; 12(4):1071-82. PubMed ID: 16322344
    [Abstract] [Full Text] [Related]

  • 15. Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women.
    Eliassen AH, Tworoger SS, Mantzoros CS, Pollak MN, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2007 Jan 15; 16(1):161-4. PubMed ID: 17220346
    [Abstract] [Full Text] [Related]

  • 16. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
    Dorgan JF, Longcope C, Stephenson HE, Falk RT, Miller R, Franz C, Kahle L, Campbell WS, Tangrea JA, Schatzkin A.
    Cancer Epidemiol Biomarkers Prev; 1996 Jul 15; 5(7):533-9. PubMed ID: 8827358
    [Abstract] [Full Text] [Related]

  • 17. Association of serum adiponectin levels with breast cancer risk.
    Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S.
    Clin Cancer Res; 2003 Nov 15; 9(15):5699-704. PubMed ID: 14654554
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.
    Cui Y, Shu XO, Cai Q, Jin F, Cheng JR, Cai H, Gao YT, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2005 May 15; 14(5):1096-101. PubMed ID: 15894658
    [Abstract] [Full Text] [Related]

  • 20. Peptide and steroid hormone levels in pre- and postmenopausal breast carcinoma.
    Bhatavdekar JM, Shah NG, Trivedi SN, Karelia NH.
    Neoplasma; 1987 May 15; 34(1):95-9. PubMed ID: 3104809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.